Researchers compared milvexian with enoxaparin for the prevention of blood clots in 1,242 patients from 18 countries undergoing knee replacement surgery who were enrolled between June 2019 and February 2021. They found that at a total daily dose of 100 mg or more, milvexian resulted in bette
Seoul [South Korea], December 28 (ANI/Global Economic): 'Paxlovid,' the COVID-19 oral treatment developed by a global pharmaceutical company Pfizer, received emergency use authorization from the Ministry of Food and Drug Safety (MFDS) on the 27th. It is expected to be used from the end of Ja
Ahmedabad (Gujarat) [India], November 23 (ANI): Pharmaceutical company Zydus Cadila on Tuesday announced that it has submitted its first "New Drug Application (NDA)" to the Drug Controller General of India for its oral pill "Desidustat" to treat anaemia in kidney patients.